Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1346
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Lexicon Pharmaceuticals Inc (LXRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program sotagliflozin (LX4211) for type 1 and type 2 diabetes and its approved product Xermelo (telotristat ethyl) for the treatment of carcinoid syndrome. Its clinical and preclinical development programs, LX2761 and LX9211 are focused at treating diabetes and neuropathic pain respectively. Lexicon has a laboratory in Texas. It has business collaborations with several pharmaceutical and biotechnology companies. Lexicon is headquartered at The Woodlands, Texas, the US.

Lexicon Pharmaceuticals Inc Key Recent Developments

Mar 12,2020: Lexicon Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides a business update
Jan 25,2020: Lexicon Pharmaceuticals Announces Real-World Data on Telotristat Ethyl's Antiproliferative Effects …
Nov 19,2019: Sterling Lexicon Enhances Small Shipment Program with Sterling Xpress
Nov 07,2019: Lexicon pharmaceuticals reports third quarter 2019 financial results and provides a business update
Oct 07,2019: Ivujivik-Puvirnituq-UQAT Group launches Inuktitut education lexicon

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Lexicon Pharmaceuticals Inc – Key Facts
Lexicon Pharmaceuticals Inc – Key Employees
Lexicon Pharmaceuticals Inc – Key Employee Biographies
Lexicon Pharmaceuticals Inc – Major Products and Services
Lexicon Pharmaceuticals Inc – History
Lexicon Pharmaceuticals Inc – Company Statement
Lexicon Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Lexicon Pharmaceuticals Inc – Business Description
Lexicon Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Lexicon Pharmaceuticals Inc – Strengths
Lexicon Pharmaceuticals Inc – Weaknesses
Lexicon Pharmaceuticals Inc – Opportunities
Lexicon Pharmaceuticals Inc – Threats
Lexicon Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 12, 2020: Lexicon Pharmaceuticals reports fourth quarter and full-year 2019 financial results and provides a business update
Nov 07, 2019: Lexicon pharmaceuticals reports third quarter 2019 financial results and provides a business update
Sep 11, 2019: Sanofi to pay Lexicon $260m over terminated Zynquista alliance
Jul 31, 2019: Lexicon Pharmaceuticals reports second quarter 2019 Financial Results and Provides a Business Update
May 01, 2019: Lexicon Pharmaceuticals reports first quarter 2019 financial results and provides a business update
Mar 13, 2019: Lexicon Pharmaceuticals announces fourth quarter and full-year 2018 financial results
Feb 08, 2019: RM LAW announces class action lawsuit against Lexicon Pharmaceuticals
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Lexicon Pharmaceuticals Inc, Key Facts
Lexicon Pharmaceuticals Inc, Key Employees
Lexicon Pharmaceuticals Inc, Key Employee Biographies
Lexicon Pharmaceuticals Inc, Major Products and Services
Lexicon Pharmaceuticals Inc, History
Lexicon Pharmaceuticals Inc, Subsidiaries
Lexicon Pharmaceuticals Inc, Key Competitors
Lexicon Pharmaceuticals Inc, Ratios based on current share price
Lexicon Pharmaceuticals Inc, Annual Ratios
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...1)
Lexicon Pharmaceuticals Inc, Annual Ratios (Cont...2)
Lexicon Pharmaceuticals Inc, Interim Ratios
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Lexicon Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Lexicon Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Lexicon Pharmaceuticals Inc, Ratio Charts
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Lexicon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TechnipFMC Plc (FTI):石油・ガス:M&Aディール及び事業提携情報
    Summary TechnipFMC plc (TechnipFMC) is a provider of oil and gas technologies, systems and services. The company focuses on subsea, surface technologies, onshore and offshore projects. Its portfolio of subsea services include drilling, asset management, installation of oil and gas field, remotely op …
  • Horama SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Horama SA (Horama) is a biotechnology company, which develops gene therapy products based on recombinant adeno-associated virus (rAAV) vectors for the treatment of rare ophthalmic diseases, including retinopathies and maculopathies. Its pipeline gene replacement products include HORA-RPE65, …
  • Rizzani De Eccher S.P.A.
    Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report Summary Rizzani De Eccher S.P.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Strabag SE:企業のM&A・事業提携・投資動向
    Strabag SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Strabag SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Goteborg Energi AB:企業の発電所・SWOT分析2018
    Goteborg Energi AB - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Daikin Industries, Ltd.:企業の戦略・SWOT・財務分析
    Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • China Eastern Airlines Corporation Limited:企業のM&A・事業提携・投資動向
    China Eastern Airlines Corporation Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Eastern Airlines Corporation Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …
  • Rex Energy Corp (REXX):石油・ガス:M&Aディール及び事業提携情報
    Summary Rex Energy Corp (Rex Energy) is an independent energy company. It carries out the acquisition, production, exploration and development of condensate, natural gas and natural gas liquids. It holds properties in Appalachian Basin. Rex Energy focuses on drilling and exploration activities in th …
  • Dover Corporation:企業の戦略・SWOT・財務情報
    Dover Corporation - Strategy, SWOT and Corporate Finance Report Summary Dover Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Green Cross Cell Corp (031390)-製薬・医療分野:企業M&A・提携分析
    Summary Green Cross Cell Corp (Green Cross Cell), formerly Innocell Corp, a subsidiary of Green Cross Corp, is a provider of immunotherapeutics for the treatment of cancer. The company offers Immuncell-LC, an anti-cancer immune therapeutic that is derived from lymphocytes of cancer patient. It offer …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Nonin Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nonin Medical Inc (Nonin) is a medical device company that provides medical monitoring solutions. The company provides noninvasive physiological monitoring devices for health professionals and consumers. Its products include pulse oximeters and sensors, regional oximeters and sensors, finger …
  • numares AG:企業の製品パイプライン分析2018
    Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics. The company’s AXINON lipoFIT, a test system used for lipoprotein profiling, while insightLP provides insights into lipid related research using lipoprotein …
  • University of Pittsburgh Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Pittsburgh Medical Center (UPMC) is a health care provider organization. It is a non-profit health care firm comprising a wide network of hospitals, clinics, and long-term care, rehabilitation and retirement facilities. The company offers several services such as commercial, me …
  • China Airlines Ltd.:企業の戦略・SWOT・財務情報
    China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ICICI Bank Ltd:戦略・SWOT・企業財務分析
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tennessee Valley Authority:企業の発電所・SWOT分析2018
    Tennessee Valley Authority - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • NTN Corporation (6472):企業の財務・戦略的SWOT分析
    NTN Corporation (6472) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • KPC Pharmaceuticals Inc (600422):製薬・医療:M&Aディール及び事業提携情報
    Summary KPC Pharmaceuticals Inc (KPC), formerly Kunming Pharmaceutical Corp, a subsidiary of Holley Group Co Ltd, is a manufacturer of botanical drugs and other pharmaceutical products. The company offers panax notoginseng, gastrodine, artemether and special botanical drugs. It also offers drugs suc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆